ATRX-mutant neuroblastomas were significantly more likely to have ALT than ATRX wild-type tumors (89.5% (17/19) vs. 22.2% (4/18); p < 0.0001, two-tailed Fisher’s exact test). This evidence concerns the gene ATRX and neuroblastoma.